- Home
- DSP vs PRQR Comparison
DSP vs PRQR Comparison
Compare DSP & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSP
- PRQR
- Stock Information
- Founded
- DSP 1999
- PRQR 2012
- Country
- DSP United States
- PRQR Netherlands
- Employees
- DSP N/A
- PRQR N/A
- Industry
- DSP EDP Services
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- DSP Technology
- PRQR Health Care
- Exchange
- DSP Nasdaq
- PRQR Nasdaq
- Market Cap
- DSP 220.3M
- PRQR 232.8M
- IPO Year
- DSP 2021
- PRQR 2014
- Fundamental
- Price
- DSP $9.30
- PRQR $1.99
- Analyst Decision
- DSP Strong Buy
- PRQR Strong Buy
- Analyst Count
- DSP 9
- PRQR 8
- Target Price
- DSP $20.44
- PRQR $8.88
- AVG Volume (30 Days)
- DSP 253.2K
- PRQR 378.7K
- Earning Date
- DSP 11-11-2025
- PRQR 11-06-2025
- Dividend Yield
- DSP N/A
- PRQR N/A
- EPS Growth
- DSP N/A
- PRQR N/A
- EPS
- DSP 0.13
- PRQR N/A
- Revenue
- DSP $318,471,000.00
- PRQR $20,129,184.00
- Revenue This Year
- DSP $16.44
- PRQR N/A
- Revenue Next Year
- DSP $15.32
- PRQR N/A
- P/E Ratio
- DSP $69.68
- PRQR N/A
- Revenue Growth
- DSP 30.92
- PRQR 8.65
- 52 Week Low
- DSP $9.07
- PRQR $1.07
- 52 Week High
- DSP $26.33
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- DSP 34.09
- PRQR 37.36
- Support Level
- DSP $9.63
- PRQR $2.21
- Resistance Level
- DSP $10.15
- PRQR $2.50
- Average True Range (ATR)
- DSP 0.37
- PRQR 0.15
- MACD
- DSP 0.07
- PRQR -0.03
- Stochastic Oscillator
- DSP 0.81
- PRQR 4.63
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.